Modified biweekly cisplatin, docetaxel plus cetuximab (TPEx) as first-line treatment for patients with recurrent/metastatic head and neck cancer.
Saved in:
| Title: | Modified biweekly cisplatin, docetaxel plus cetuximab (TPEx) as first-line treatment for patients with recurrent/metastatic head and neck cancer. |
|---|---|
| Authors: | Fuchs H; Division of Clinical Oncology, Department of Internal Medicine I & Comprehensive Cancer Center, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria., Pammer J; Department of Pathology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria., Minichsdorfer C; Division of Clinical Oncology, Department of Internal Medicine I & Comprehensive Cancer Center, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria., Posch D; Division of Clinical Oncology, Department of Internal Medicine I & Comprehensive Cancer Center, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria., Kornek G; Division of Clinical Oncology, Department of Internal Medicine I & Comprehensive Cancer Center, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria., Aretin MB; Pharmacy Department, General Hospital Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria., Fuereder T; Division of Clinical Oncology, Department of Internal Medicine I & Comprehensive Cancer Center, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. thorsten.fuereder@meduniwien.ac.at. |
| Source: | Medical oncology (Northwood, London, England) [Med Oncol] 2018 Feb 07; Vol. 35 (3), pp. 32. Date of Electronic Publication: 2018 Feb 07. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 9435512 Publication Model: Electronic Cited Medium: Internet ISSN: 1559-131X (Electronic) Linking ISSN: 13570560 NLM ISO Abbreviation: Med Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 29411154 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Modified biweekly cisplatin, docetaxel plus cetuximab (TPEx) as first-line treatment for patients with recurrent/metastatic head and neck cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Fuchs+H%22">Fuchs H</searchLink>; Division of Clinical Oncology, Department of Internal Medicine I & Comprehensive Cancer Center, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Pammer+J%22">Pammer J</searchLink>; Department of Pathology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Minichsdorfer+C%22">Minichsdorfer C</searchLink>; Division of Clinical Oncology, Department of Internal Medicine I & Comprehensive Cancer Center, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Posch+D%22">Posch D</searchLink>; Division of Clinical Oncology, Department of Internal Medicine I & Comprehensive Cancer Center, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Kornek+G%22">Kornek G</searchLink>; Division of Clinical Oncology, Department of Internal Medicine I & Comprehensive Cancer Center, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Aretin+MB%22">Aretin MB</searchLink>; Pharmacy Department, General Hospital Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Fuereder+T%22">Fuereder T</searchLink>; Division of Clinical Oncology, Department of Internal Medicine I & Comprehensive Cancer Center, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. thorsten.fuereder@meduniwien.ac.at. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229435512%22">Medical oncology (Northwood, London, England)</searchLink> [Med Oncol] 2018 Feb 07; Vol. 35 (3), pp. 32. <i>Date of Electronic Publication: </i>2018 Feb 07. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9435512 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1559-131X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213570560%22">13570560 </searchLink><i>NLM ISO Abbreviation: </i>Med Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=29411154 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s12032-018-1087-6 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 32 Titles: – TitleFull: Modified biweekly cisplatin, docetaxel plus cetuximab (TPEx) as first-line treatment for patients with recurrent/metastatic head and neck cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Fuchs H – PersonEntity: Name: NameFull: Pammer J – PersonEntity: Name: NameFull: Minichsdorfer C – PersonEntity: Name: NameFull: Posch D – PersonEntity: Name: NameFull: Kornek G – PersonEntity: Name: NameFull: Aretin MB – PersonEntity: Name: NameFull: Fuereder T IsPartOfRelationships: – BibEntity: Dates: – D: 07 M: 02 Text: 2018 Feb 07 Type: published Y: 2018 Identifiers: – Type: issn-electronic Value: 1559-131X Numbering: – Type: volume Value: 35 – Type: issue Value: 3 Titles: – TitleFull: Medical oncology (Northwood, London, England) Type: main |
| ResultId | 1 |
